exp date isn't null, but text field is
This guideline is applicable to doctors, nurses, ANNPs working with neonates in the West-of-Scotland. This guideline is intended to provide guidance on the acute management of suspected arterial thrombosis in the neonate.
Neonatal arterial thrombosis is uncommon in the neonatal period but can be life threatening and a cause of serious long-term morbidity. The single most important risk factor identified in the literature is secondary to indwelling arterial catheters (umbilical arterial catheters, peripheral arterial lines).
The initial diagnosis of arterial thrombosis is a clinical one. It is a clinical emergency and should be discussed promptly with the Neonatal Consultant on–call. If plastic surgery input is needed, baby should be promptly discussed with the team at the Royal Hospital for Children, Glasgow.
Clear documentation in the baby’s notes of:
Aims:
DOs
DON’Ts
Review Patient in One Hour
If there is no improvement further investigations and referral is essential.
Urgent referral to Royal Hospital for Children, Glasgow. Call the ScotSTAR emergency line on 03333 990 240 and request a conference call with the following participants:
Further imaging: if not available locally will be performed at RHC, Glasgow
The only medical management that should be initiated in the first 12 hours is unfractionated heparin. Decision to treat requires MDT discussions with the neonatal team, plastics team and haematology team. Dosing and monitoring guidance available through the link below:
Anti-Thrombotic therapy, Haematology
Unfractionated heparin is the treatment of choice for initial anticoagulation. Going forward, there is an option to change to subcutaneous low molecular weight heparin.
There is a 12 hour window for assessment of the patient for consideration of thrombolysis and/or surgical intervention. This decision should be made with reference to the location of the insult and gestation of the infant and will involve input from neonatology, plastics and haematology.
Last reviewed: 03 June 2024
Next review: 01 June 2027
Author(s): Lavinia Raeside, Advanced Neonatal Nurse Practitioner, RHC, Glasgow; Dr Andrew MacLaren, Consultant Neonatologist, RHC, Glasgow
Co-Author(s): Other professionals consulted: Mr David McGill, Consultant Plastic Surgeon, RHC, Glasgow; Claire Gardner, Tissue Viability Nurse, RHC, Glasgow.
Approved By: West of Scotland Neonatal MCN